TEHELMZA Trademark

Trademark Overview

On Monday, November 15, 2021, a trademark application was filed for TEHELMZA with the United States Patent and Trademark Office. The USPTO has given the TEHELMZA trademark a serial number of 97125172. The federal status of this trademark filing is REGISTERED as of Tuesday, September 12, 2023. This trademark is owned by Glaxo Group Limited. The TEHELMZA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
tehelmza

General Information

Serial Number97125172
Word MarkTEHELMZA
Filing DateMonday, November 15, 2021
Status700 - REGISTERED
Status DateTuesday, September 12, 2023
Registration Number7160218
Registration DateTuesday, September 12, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Thursday, November 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 24, 2023CASE RETURNED TO EXAMINATION
Wednesday, May 24, 2023NOTICE OF ALLOWANCE CANCELLED
Wednesday, May 24, 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, May 22, 2023ASSIGNED TO PETITION STAFF
Tuesday, May 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2023SOU EXTENSION 1 GRANTED
Friday, May 12, 2023SOU EXTENSION 1 FILED
Friday, May 12, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 12, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, December 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 8, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 2, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, August 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 18, 2021NEW APPLICATION ENTERED

Related Keywords

tehelmza treatment preparations pharmaceutical diseases disorders hepatological respiratory genitourinary cardiopulmonary neurological